To find out simple technique in order to assess the fibrosis changes in the liver in Liver disease (Hepatitis B,Hepatitis C and NAFLD).
Not Applicable
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedHealth Condition 2: null- Hepatitis B,Hepatitis C and Non Alcoholic Fatty Liver DiseaseHealth Condition 3: K769- Liver disease, unspecified
- Registration Number
- CTRI/2018/02/012238
- Lead Sponsor
- Institute of liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 18 years and above Patients who underwent liver biopsy with underlying etiology as HBV, HCV, NASH or cryptogenic or ALD (inpatient or outpatient) Metavir Fibrosis Score F0-3 for prospective study design
Exclusion Criteria
Not willing to participate in the study Patients with chronic liver disease of other
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method